ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

REPR Repro Med Systems Inc

4.00
0.00 (0.00%)
After Hours
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Repro Med Systems Inc NASDAQ:REPR NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.00 3.86 4.09 0 01:00:00

Statement of Changes in Beneficial Ownership (4)

29/01/2020 10:19pm

Edgar (US Regulatory)


FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Manko Joseph M. Jr.
2. Issuer Name and Ticker or Trading Symbol

REPRO MED SYSTEMS INC [ KRMD ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    __X__ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

1717 ARCH STREET, 39TH FLOOR
3. Date of Earliest Transaction (MM/DD/YYYY)

1/24/2020
(Street)

PHILADELPHIA, PA 19103
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 1/24/2020  J(1)  125931 D$0 3283593 I By Horton Freedom, L.P. (2)
Common Stock         7367381 I By Horton Capital Partners Fund, LP (2)
Common Stock         1525039 I By Horton Capital Management, LLC (2)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares

Explanation of Responses:
(1) See Exhibit 99.1 to this Form 4 for explanation of note (1).
(2) See Exhibit 99.1 to this Form 4 for explanation of note (2).

Remarks:
The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Manko Joseph M. Jr.
1717 ARCH STREET
39TH FLOOR
PHILADELPHIA, PA 19103
XX

Horton Capital Management, LLC
1717 ARCH STREET
39TH FLOOR
PHILADELPHIA, PA 19103

X

Horton Capital Partners, LLC
1717 ARCH STREET
39TH FLOOR
PHILADELPHIA, PA 19103

X

Horton Capital Partners Fund, L.P.
1717 ARCH STREET
39TH FLOOR
PHILADELPHIA, PA 19103

X


Signatures
/s/ Joseph M. Manko, Jr.1/28/2020
**Signature of Reporting PersonDate

/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Management, LLC1/28/2020
**Signature of Reporting PersonDate

/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Partners, LLC1/28/2020
**Signature of Reporting PersonDate

/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Partners, LLC, the General Partner of Horton Capital Partners Fund, LP and Horton Freedom, L.P.1/28/2020
**Signature of Reporting PersonDate

1 Year Repro Med Systems Chart

1 Year Repro Med Systems Chart

1 Month Repro Med Systems Chart

1 Month Repro Med Systems Chart